Status:

COMPLETED

Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung

Lead Sponsor:

Mauna Kea Technologies

Conditions:

Lung Neoplasms

Disorder Related to Lung Transplantation

Eligibility:

All Genders

18+ years

Brief Summary

Patients will be enrolled that are undergoing bronchoscopy for diagnosis of discrete lung lesions or for detection of acute rejection following lung transplants. The hypothesis is that bronchoscopy to...

Detailed Description

The primary aim of this study is to develop the criteria to differentiate healthy versus diseased tissue in patient with discrete lung lesions or to characterize acute lung rejection in patients with ...

Eligibility Criteria

Inclusion

  • Male or female \> 18 years of age
  • Willing and able to comply with study procedures and provide written informed consent to participate in the study
  • Indeterminate discrete nodule(s) suspicious for cancer scheduled for diagnostic bronchoscopy
  • Newly discovered \&/or prior discovered non classified nodules, hard to define based on CT scan
  • Purpose of bronchoscopy is for diagnosis of lesion(s) - can be solitary pulmonary nodule or multiple lesions
  • All lesion locations are acceptable
  • Any patient undergoing clinically indicated bronchoscopies after lung transplantation
  • Patients post transplant showing clinical signs of acute rejection \>3 weeks; \< 1 year
  • Patient with single or double lung transplant

Exclusion

  • Contraindication to short-acting anesthetic agents;
  • Contraindications to transbronchial biopsy
  • Bleeding diathesis;
  • A pacemaker/defibrillator;
  • A diagnosis by other means (sputum cytology, microbiology).
  • Unwilling To Consent
  • Unable To Safely Tolerate A Bronchoscopic Procedure
  • Unwilling To Comply With Surveillance Bronchoscopy Follow Up
  • Chronic Rejection
  • Fungal Disease
  • Ax Histological Assessment Or Incomplete Biopsy Procedure Should Be Considered As A Screen Failure

Key Trial Info

Start Date :

February 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 24 2016

Estimated Enrollment :

99 Patients enrolled

Trial Details

Trial ID

NCT01793246

Start Date

February 1 2013

End Date

December 24 2016

Last Update

August 29 2017

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

St. Joseph's Medical Center

Phoenix, Arizona, United States, 85013

2

Mayo Clinic

Jacksonville, Florida, United States, 32082

3

University of Chicago

Chicago, Illinois, United States, 60637

4

Columbus Regional Hospital

Columbus, Indiana, United States, 47201